Results 11 to 20 of about 9,257 (204)

Visfatin/Nampt: An Adipokine with Cardiovascular Impact [PDF]

Mediators of Inflammation, 2013
Adipose tissue is acknowledged as an endocrine organ that releases bioactive factors termed adipokines. Visfatin was initially identified as a novel adipokine with insulin-mimetic properties in mice.
Tania Romacho, Carlos F. Sánchez-Ferrer, Concepción Peiró   +2 more
doaj   +6 more sources

Visfatin Reduces Gap Junction Mediated Cell-to-Cell Communication in Proximal Tubule-Derived Epithelial Cells [PDF]

Cellular Physiology and Biochemistry, 2013
Background/Aims: In the current study we examined if the adipocytokine, visfatin, alters connexin-mediated intercellular communication in proximal tubule-derived epithelial cells.
Claire E. Hills, Michael I. Kerr, Mark J. Wall, Paul E. Squires   +3 more
doaj   +2 more sources

VISFATIN AND CARDIOVASCULAR PROTECTION [PDF]

Journal of Drug Delivery and Therapeutics, 2014
In cardiovascular diseases, visfatin was initially proposed as a marker of atherosclerosis, endothelial dysfunction, and vascular damage. Objectives: we try to elucidate the relationship between visfatin and cardiovascular diseases as different controversial studies about visfatin role were found.
Rezk, Mohamad Yosof
openaire   +2 more sources

Visfatin Levels in Subclinical Hypothyroidism

International Journal of Peptide Research and Therapeutics, 2015
Alterations in thyroid function are associated with changes in body weight, metabolism, and low-grade inflammation abnormal thyroid function may be associated with disturbances in the production of adipokines also. Although there have been studies showing changes in visfatin levels in thyroid dysfunction, exact relationship between them was still ...
Guzin Fidan Yaylali, Sebahat Turgut, Fulya Akin, Seyma Ozkan, Mehmet Tural, Melek Tunc Ata, Can Ozlu, Kamil İsler   +7 more
openaire   +5 more sources

Visfatin/PBEF and Atherosclerosis-Related Diseases

Current Vascular Pharmacology, 2010
Visfatin is highly expressed in adipose tissue (mainly by the stromal cells), but it is also ubiquitously present in most tissues. Visfatin, which plays a role in nicotinamide adenine dinucleotide (NAD) biosynthesis, has been implicated in inflammatory states. Controversial results exist about the expression, circulating levels and the role of visfatin
Filippatos, T. D., Randeva, H. S., Derdemezis, C. S., Elisaf, M. S., Mikhailidis, D. P.   +4 more
openaire   +4 more sources

Serum visfatin levels in acute appendicitis [PDF]

International Journal of Surgery, 2010
The clinical importance of the novel adipokine visfatin are still largely unknown. Our aim was to evaluate diagnostic accuracy of visfatin serum concentrations in Acute appendicitis(AA). Total of 34 patients with preoperative AA diagnosis (18 men and 16 women, mean age 28.8 +/- 10.9 years) were enrolled this study.
Isman, Ferruh Kemal, Zulfikaroglu, Baris, Acar, Atahan, Koc, Mahmut, Tez, Mesut, Kucur, Mine   +5 more
openaire   +3 more sources

Maternal visfatin concentration in normal pregnancy [PDF]

Journal of Perinatal Medicine, 2008
AbstractObjective:Adipose tissue has now emerged as a powerful endocrine organ via the production of adipokines. Visfatin, a novel adipokine with diabetogenic and immuno-modulatory properties has been implicated in the pathophysiology of insulin resistance in patients with obesity and Type-2 diabetes mellitus.
Shali, Mazaki-Tovi, Roberto, Romero, Juan Pedro, Kusanovic, Edi, Vaisbuch, Offer, Erez, Nandor Gabor, Than, Tinnakorn, Chaiworapongsa, Chia-Ling, Nhan-Chang, Percy, Pacora, Francesca, Gotsch, Lami, Yeo, Sun Kwon, Kim, Samuel S, Edwin, Sonia S, Hassan, Pooja, Mittal   +14 more
openaire   +4 more sources

Visfatin concentrations in patients with endometrial cancer

Gynecological Endocrinology, 2014
Visfatin is one of the most recent proteins shown to be highly expressed in adipose tissue. The purpose of this study was to determine visfatin levels in patients with endometrial cancer (EC).A total of 90 patients (46 EC patients and 44 healthy controls) were included in the study. Fasting venous blood samples were collected from all patients.
Avcıoğlu, Sümeyra Nergiz, Altınkaya, Sündüz Özlem, Küçük, Mert, Yüksel, Hasan, Ömürlü, İmran Kurt, Yanık, Serdar   +5 more
openaire   +4 more sources

Visfatin and Cardio–Cerebro–Vascular Disease

Journal of Cardiovascular Pharmacology, 2012
Nicotinamide phosphoribosyltransferase is the rate-limiting enzyme that catalyzes the first step in the biosynthesis of nicotinamide adenine dinucleotide from nicotinamide. This protein was originally cloned as a putative pre-B cell colony-enhancing factor and also found to be a visceral fat-derived adipokine (visfatin).
Vanhoutte, PM, Miao, CY, Wang, P
openaire   +5 more sources

The role of visfatin in cancer proliferation, angiogenesis, metastasis, drug resistance and clinical prognosis

Cancer Management and Research, 2019
Tsung-Chieh LinGenomic Medicine Core Laboratory, Chang Gung Memorial Hospital, Linkou, TaiwanAbstract: Visfatin, also known as nicotinamide phosphoribosyltransferase or pre-B-cell colony-enhancing factor (PBEF), is an adipocytokine secreted by adipocytes,
Lin TC
doaj   +1 more source